General form of registration statement for all companies including face-amount certificate companies

INCOME TAXES (Details 2)

v3.21.2
INCOME TAXES (Details 2) - USD ($)
 4 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]        
Expected income tax benefit at U.S. rates   $ 5,549,000 $ 12,361,000 $ 8,695,000
Difference between U.S. rate and rates applicable to subsidiaries in other jurisdictions   (301,000) (930,000) (549,000)
Expenditures not deductible for tax purposes   (43,000) (136,000) (761,000)
Acquired net operating losses (a)   25,028,000
Tax rate changes outside the U.S.   5,368,000
Expiry of foreign taxable losses   6,218,000 (363,000)
Other   502,000 (742,000) (2,072,000)
Valuation allowance on tax benefits $ 42,564 (13,385,000) (16,395,000) (30,422,000)
UK R&D tax credits   2,242,000 696,000
Income tax benefit (expense) $ 0 $ 782,000 $ (474,000) $ 252,000